Gamma counters

PO-322.

ARD-266 is a highly potent and von Hippel-Lindau E3 ligase-based Androgen Receptor ( AR ) PROTAC degrader. ARD-266 effectively induces degradation of AR protein in AR -positive LNCaP, VCaP, and 22Rv1 prostate cancer cell lines with DC 50 values of

ARD-266 is a highly potent and von Hippel-Lindau E3 ligase-based Androgen Receptor ( AR ) PROTAC degrader. ARD-266 effectively induces degradation of AR protein in AR -positive LNCaP, VCaP, and 22Rv1 prostate cancer cell lines with DC 50 values of

ARD-266.

ARD-266.

Biochemical Test:SDS-PAGE (purity &gt: 80%): Western blot with i: anti-TIF1 gamma autoantibody-positive sample: ii: monoclonal anti-His-tag antibody.Calculated Isoelectric Point:pH 6.38.

Biochemical Test:SDS-PAGE (purity &gt: 80%): Western blot with i: anti-TIF1 gamma autoantibody-positive sample: ii: monoclonal anti-His-tag antibody.Calculated Isoelectric Point:pH 6.38.

InformationSubasumstat (TAK-981) Subasumstat (TAK-981) is a novel, selective inhibitor of the SUMOylation enzymatic cascade with potential immune-activating and antineoplastic activities.TargetsSUMOylation enzymatic cascadeIn vitroIn both mouse

InformationSubasumstat (TAK-981) Subasumstat (TAK-981) is a novel, selective inhibitor of the SUMOylation enzymatic cascade with potential immune-activating and antineoplastic activities.TargetsSUMOylation enzymatic cascadeIn vitroIn both mouse

InformationSubasumstat (TAK-981) Subasumstat (TAK-981) is a novel, selective inhibitor of the SUMOylation enzymatic cascade with potential immune-activating and antineoplastic activities.TargetsSUMOylation enzymatic cascadeIn vitroIn both mouse

InformationSubasumstat (TAK-981) Subasumstat (TAK-981) is a novel, selective inhibitor of the SUMOylation enzymatic cascade with potential immune-activating and antineoplastic activities.TargetsSUMOylation enzymatic cascadeIn vitroIn both mouse

Seclidemstat.